We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LABS market cap is 2.19B. The company's latest EPS is CAD -0.0326 and P/E is -2.45.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 129.25M | 36.01M | 21.71M | 22.12M | 34.98M |
| Operating Income | 6.94M | -72.58M | -47.25M | -28.78M | -19.37M |
| Net Income | 1.65M | -66.35M | -54.8M | -29.98M | -13.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 168.83M | 118.23M | 92.36M | 65.5M | 63.94M |
| Total Liabilities | 37.6M | 39.82M | 9.22M | 9.49M | 10.93M |
| Total Equity | 131.23M | 78.41M | 83.15M | 56.01M | 53.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -25.27M | -37.77M | -13.21M | -16.07M | -12.34M |
| Investing | -32.55M | -7.45M | 35k | 5.16M | 6.87M |
| Financing | 88.5M | 26.42M | 27.8M | 796k | -368k |
| Market Cap | 2.19B |
| Price to Earnings Ratio | -2.45 |
| Price to Sales Ratio | 0.92 |
| Price to Cash Ratio | 1.79 |
| Price to Book Ratio | 0.61 |
| Dividend Yield | - |
| Shares Outstanding | 401.4M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.02 (0.37%) |
| Company Name | MediPharm Labs Corp |
| Address |
151 john st barrie, ontario L4N 2L1 |
| Website | https://www.medipharmlabs.com |
| Industry | pension,health,welfare funds (6371) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
